CELULARITY IMPACT
Live / Registered — Registered (as of 05 Jul 2022)
What this means for you
Registered since 05 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97265928
- Registration number
- 6782541
- Mark type
- Stylized text
- Filed
- 14 Feb 2022
- Published for opposition
- 19 Apr 2022
- Registered
- 05 Jul 2022
- Attorney of record
- Camille M. Miller
Goods and services
- Class 040 — Treatment of materials: Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
- Class 042 — Scientific and technological services: Research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; scientific and technological services, namely, scientific research, analysis, and testing in the field of genomics, biotechnology, and pharmaceuticals; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing; research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals
Owner
- Celularity Inc., Florham Park, NJ, US
- Celularity Inc., Florham Park, NJ, US
- Celularity Inc., Florham Park, NJ, US
Prior registrations
Prosecution history
- 05 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Apr 2022 — PUBLISHED FOR OPPOSITION
- 30 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Mar 2022 — ASSIGNED TO LIE
- 11 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Mar 2022 — EXAMINER'S AMENDMENT ENTERED
- 11 Mar 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Mar 2022 — EXAMINERS AMENDMENT E-MAILED
- 11 Mar 2022 — EXAMINERS AMENDMENT -WRITTEN
- 01 Mar 2022 — ASSIGNED TO EXAMINER
- 18 Feb 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Feb 2022 — NEW APPLICATION ENTERED